Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

IIR 02-109 – HSR Study

 
IIR 02-109
Risk-Adjusted Mortality Rates as an Indicator for Outpatient Quality
Alfredo J. Selim, MD MPH
VA Bedford HealthCare System, Bedford, MA
Bedford, MA
Funding Period: January 2004 - December 2005
Portfolio Assignment: Quality Measurement Development
BACKGROUND/RATIONALE:
In an environment of health care restructuring and shifting from inpatient and to outpatient care, the Veteran Health Administration (VHA), acknowledges that the quality of outpatient care needs to be monitored. We have recently suggested that risk-adjusted mortality rates have potential for assessing quality of outpatient care. Our work showed that it is feasible to develop a clinically credible risk adjustment model with good statistical performance for monitoring the outcome of mortality in ambulatory populations. The resulting risk-adjusted mortality rates altered assessments of performance of the Veterans Integrated Service Networks (VISNs) when compared with unadjusted mortality rates. However, this work is preliminary and requires additional evaluation before we can advocate its use in profiling VISNs and facilities and their quality of care.

OBJECTIVE(S):
To explore the performance of the risk-adjusted model and the extent to which this model captures quality of care as opposed to random variation. To evaluate the association of the risk-adjusted mortality rates with process measures and other performance indicators that the VHA uses for profiling VISNs and facilities.

METHODS:
To evaluate the model performance model discrimination and calibration using a cohort of approximately 800,000 veterans. To examine the stability of risk-adjusted mortality rates over time, we will compare model summaries of patients for two time periods of 18 months each. To examine the association between mortality rates and processes of care, we will use two analytical approaches. First, we will perform a correlation analysis between VISN's and facilities’ Clinical Practice Guidelines and risk adjusted mortality data. Second, twenty percent of the patients in the Large Health Survey (160,000 veterans) were surveyed about their perception of the quality of the care, access to health care, coordination /continuity of care, and interaction with caregivers. We are interested in comparing how many and which facilities are considered outliers using
patients’ ratings of health care quality and how risk-adjusted mortality rates relate to these findings.

FINDINGS/RESULTS:
The multistage multivariate models showed a gain in the explanatory power of the models for mortality by adding comorbidities and baseline health status. Older patients, males, whites, and those with a higher number of comorbidities were more likely to die. In contrast, married patients, those with higher incomes, those employed, and those with higher baseline PCS and MCS scores were less likely to die. When we compared the model performance using the 1999 cohort of 705,719 VA users with the 1998 cohort of 31,825, the c-statistics of the models were similar, 0.77 and 0.79 respectively. Our results showed that the risk adjusted mortality were stable over time using a two-way analysis of variance, with VISN as one factor, and time period as the other. Looking at the correlation analysis, there is some association between the rates during the two subsequent 18 months-periods (r=0.65, p=0.001). The patient perceptions of not being able to get a referral to a specialist and poor quality of care were significantly associated with prospective mortality at the VISN level (r-0.50, p=0.04 and r=-0.45, p=0.03; respectively). There were no significant associations between the adjusted mortality rates and the EPRP or the Preventive Services scores at the VISN level.

IMPACT:
Risk-adjusted models that are validated and predict mortality are important evidence of outcomes. Thus, this proposal will expand and greatly strengthen risk adjustment models for comparisons of outcomes at the VISN-level. The VHA performance measurement system can incorporate this methodology into their process of evaluation.


External Links for this Project

Dimensions for VA

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

Learn more about Dimensions for VA.

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.
    Search Dimensions for this project

PUBLICATIONS:

Journal Articles

  1. Selim AJ, Rogers W, Qian SX, Brazier J, Kazis LE. A preference-based measure of health: the VR-6D derived from the veterans RAND 12-Item Health Survey. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2011 Oct 1; 20(8):1337-47. [view]
  2. Selim AJ, Kazis LE, Rogers W, Qian SX, Rothendler JA, Spiro A, Ren XS, Miller DR, Selim BJ, Fincke BG. Change in health status and mortality as indicators of outcomes: comparison between the Medicare Advantage Program and the Veterans Health Administration. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2007 Sep 1; 16(7):1179-91. [view]
  3. Selim AJ, Berlowitz D, Kazis LE, Rogers W, Wright SM, Qian SX, Rothendler JA, Spiro A, Miller D, Selim BJ, Fincke BG. Comparison of health outcomes for male seniors in the Veterans Health Administration and Medicare Advantage plans. Health services research. 2010 Apr 1; 45(2):376-96. [view]
  4. Selim AJ, Kazis LE, Qian S, Rothendler JA, Spiro A, Rogers W, Haffer SC, Wright SM, Miller D, Selim BJ, Fincke BG. Differences in risk-adjusted mortality between Medicaid-eligible patients enrolled in Medicare advantage plans and those enrolled in the veterans health administration. The Journal of ambulatory care management. 2009 Jul 1; 32(3):232-40. [view]
  5. Rajan M, Lai KC, Tseng CL, Qian S, Selim A, Kazis L, Pogach L, Sinha A. Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2013 Feb 1; 22(1):53-64. [view]
  6. Selim AJ, Fincke G, Berlowitz DR, Cong Z, Miller DR, Ren XS, Qian S, Rogers W, Lee A, Rosen AK, Selim BJ, Kazis LE. No racial differences in mortality found among Veterans Health Administration out-patients. Journal of clinical epidemiology. 2004 May 1; 57(5):539-42. [view]
  7. Selim AJ, Kazis LE, Rogers W, Qian S, Rothendler JA, Lee A, Ren XS, Haffer SC, Mardon R, Miller D, Spiro A, Selim BJ, Fincke BG. Risk-adjusted mortality as an indicator of outcomes: comparison of the Medicare Advantage Program with the Veterans' Health Administration. Medical care. 2006 Apr 1; 44(4):359-65. [view]
  8. Selim AJ, Berlowitz D, Fincke G, Rogers W, Qian S, Lee A, Cong Z, Selim BJ, Ren XS, Rosen AK, Kazis LE. Use of risk-adjusted change in health status to assess the performance of integrated service networks in the Veterans Health Administration. International journal for quality in health care : journal of the International Society for Quality in Health Care / ISQua. 2006 Feb 1; 18(1):43-50. [view]
Conference Presentations

  1. Selim AJ, Berlowitz DR, Kazis LE, Rogers W, Qian S, Rothendler JA, Spiro A, Miller DR, Selim B, Fincke BG. Comparison of the Performance of the VHA versus the Medicare Advantage Plans: A National Comparison of two Large Systems Using Health Outcomes. Paper presented at: VA HSR&D National Meeting; 2008 Feb 14; Baltimore, MD. [view]


DRA: Health Systems Science, Aging, Older Veterans' Health and Care
DRE: Epidemiology, Treatment - Observational
Keywords: Outpatient, Quality assessment, Risk adjustment
MeSH Terms: none

Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.